Hartmut Link
Impact in
- Hematology top 0.2%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Erythropoietin and Anemia Treatment
- Iron Metabolism and Disorders
- Oncology top 1%
- Neutropenia and Cancer Infections
Papers in
- Hematology 77
- Hematopoietic Stem Cell Transplantation 33
- Acute Myeloid Leukemia Research 33
- Erythropoietin and Anemia Treatment 15
- Chronic Myeloid Leukemia Treatments 12
- Oncology 71
- Neutropenia and Cancer Infections 47
- Co-authors
- Matti Aapro (8 shared papers)Carsten Bokemeyer (10 shared papers)Georg Maschmeyer (17 shared papers)Lazzaro Repetto (2 shared papers)Jan Foubert (2 shared papers)Anders Österborg (2 shared papers)A. Courdi (2 shared papers)Pierre Soubeyran (2 shared papers)
- Journals
- Annals of Hematology (16 papers)Supportive Care in Cancer (10 papers)Blood (9 papers)British Journal of Haematology (6 papers)Journal of Clinical Oncology (6 papers)
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
Hartmut Link
140 papers receiving 5.2k citations
Peers
Comparison fields: 5 of 117
- Hematology 2.3k
- Oncology 1.8k
- Biochemistry 399
- Genetics 522
- Clinical Biochemistry 196
Countries citing papers authored by Hartmut Link
This map shows the geographic impact of Hartmut Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hartmut Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hartmut Link more than expected).
Fields of papers citing papers by Hartmut Link
This network shows the impact of papers produced by Hartmut Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hartmut Link. The network helps show where Hartmut Link may publish in the future.
Co-authors
The 25 scholars most cited alongside Hartmut Link, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 161 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 491 | |
| 2 | 1993 | 401 | |
| 3 | 2006 | 294 | |
| 4 | 2004 | 254 | |
| 5 | 1998 | 223 | |
| 6 | 2017 | 182 | |
| 7 | 2003 | 175 | |
| 8 | 1992 | 158 | |
| 9 | 2003 | 144 | |
| 10 | 2007 | 132 | |
| 11 | 2008 | 129 | |
| 12 | 1996 | 128 | |
| 13 | 2013 | 127 | |
| 14 | 1997 | 122 | |
| 15 | 1994 | 113 | |
| 16 | 2015 | 112 | |
| 17 | 2017 | 108 | |
| 18 | Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): an additional deletion in 9q is an adverse prognostic factor. | 1996 | 108 |
| 19 | 1994 | 87 | |
| 20 | 1989 | 84 |
About Hartmut Link
Hartmut Link is a scholar working on Hematology, Oncology, Genetics, Genetics and Molecular Biology, having authored 161 papers that have together received 5.5k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (47 papers), Hematopoietic Stem Cell Transplantation (33 papers), Acute Myeloid Leukemia Research (33 papers), Blood disorders and treatments (20 papers), Hematological disorders and diagnostics (16 papers), Erythropoietin and Anemia Treatment (15 papers), Chronic Myeloid Leukemia Treatments (12 papers) and Acute Lymphoblastic Leukemia research (9 papers). The work is most often cited by research in Hematology (2.3k citations), Oncology (1.8k citations), Biochemistry (399 citations), Genetics (522 citations) and Clinical Biochemistry (196 citations). Hartmut Link has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Matti Aapro, Carsten Bokemeyer, Georg Maschmeyer, Lazzaro Repetto, Jan Foubert, Anders Österborg, A. Courdi, Pierre Soubeyran, Augustin Ferrant and Norbert Schmitz. Their work appears in journals such as Annals of Hematology, Supportive Care in Cancer, Blood, British Journal of Haematology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.